Dr. Jihad Khattab, MD

Dr. Khattab practices at Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. Khattab's NPI, 1730126111, was assigned on June 2, 2006. Dr. Khattab holds Oklahoma license 21150.

Dr. Khattab's primary practice is Saint Francis Hospital, at 6161 South Yale, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 494-8467.

Dr. Khattab's primary practice is Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System. Dr. Khattab is also affiliated with Saint Francis Hospital South. The medical group on file is Warren Clinic. Dmand AI also links Dr. Khattab to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khattab practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Khattab's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Khattab is licensed in Oklahoma.

CMS data shows 1,819 Medicare services from Dr. Khattab across 6 procedure codes in 2024, for 355 Medicare patients. Medicare paid $71,664 for them.

CMS counts 355 Medicare patients who saw Dr. Khattab in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khattab's median patient age at 73, with 58% women.

In 2024, Dr. Khattab wrote 1,300 Medicare Part D claims for 185 patients. 83% of them were for generic drugs. CMS names the drug for 1,107 of them, across 37 drugs with 11 or more claims each, at $1,706,709 in total drug cost. In 2023, CMS named 1,163 claims across 38 drugs.

Dr. Khattab accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 170 general payments to Dr. Khattab from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Pfizer Inc. paid the most, $581.